Rigel Pharmaceuticals EPS Diluted from Accounting Change (Quarterly) Insights

Rigel Pharmaceuticals, Inc. (RIGL)

37.64 +1.30 (+3.58%) USD | NASDAQ | Jan 21, 16:00

37.57 -0.07 (-0.19%) After-Hours: 20:00

View EPS Diluted from Accounting Change (Quarterly) for RIGL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Accounting Change (Quarterly) Benchmarks

Start Trial

Nektar Therapeutics	--
Ironwood Pharmaceuticals, Inc.	--
Catalyst Pharmaceuticals, Inc.	--
Perspective Therapeutics, Inc.	--
Vertex Pharmaceuticals, Inc.	--